|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Adachi E, Maeda T, Matsumata T, et al:
Risk factors for intra-hepatic recurrence in human small
hepatocellular carcinoma. Gastroenterology. 108:768–775. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ikeda K, Saitoh S, Tsubota A, et al: Risk
factors for tumor recurrence and prognosis after curative resection
of hepatocellular carcinoma. Cancer. 71:19–25. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iizuka N, Hamamoto Y and Oka M: Predicting
individual outcomes in hepatocellular carcinoma. Lancet.
364:1837–1839. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iizuka N, Oka M, Yamada-Okabe H, et al:
Oligonucleotide microarray for prediction of early intrahepatic
recurrence of hepatocellular carcinoma after curative resection.
Lancet. 361:923–929. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Llovet JM, Ricci S, Mazzaferro V, et al:
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med.
359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Henderson JM, Sherman M, Tavill A,
Abecassis M, Chejfec G and Gramlich T: AHPBA/AJCC consensus
conference on staging of hepatocellular carcinoma: consensus
statement. HPB (Oxford). 5:243–250. 2003. View Article : Google Scholar
|
|
8
|
Nanashima A, Sumida Y, Morino S, et al:
The Japanese integrated staging score using liver damage grade for
hepatocellular carcinoma in patients after hepatectomy. Eur J Surg
Oncol. 30:765–770. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tateishi R, Yoshida H, Shiina S, et al:
Proposal of a new prognostic model for hepatocellular carcinoma: an
analysis of 403 patients. Gut. 54:419–425. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kudo M, Chung H, Haji S, et al: Validation
of a new prognostic staging system for hepatocellular carcinoma:
the JIS score compared with the CLIP score. Hepatology.
40:1396–1405. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
A new prognostic system for hepatocellular
carcinoma: a retrospective study of 435 patients: the Cancer of the
Liver Italian Program (CLIP) investigators. Hepatology. 28:751–755.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pugh RN, Murray-Lyon IM, Dawson JL,
Pietroni MC and Williams R: Transection of the oesophagus for
bleeding oesophageal varices. Br J Surg. 60:646–649. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
The general rules for the clinical and
pathological study of primary liver cancer. Kanehara; Tokyo:
2010
|
|
14
|
Mazzaferro V, Regalia E, Doci R, et al:
Liver transplantation for the treatment of small hepatocellular
carcinomas in patients with cirrhosis. N Engl J Med. 334:693–699.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Akaike H: A new look at the statistical
model identification. IEEE trans. Automatic Control. AC-19:716–723.
1974. View Article : Google Scholar
|
|
16
|
Nanashima A, Sumida Y, Abo T, et al:
Modified Japan Integrated Staging is currently the best available
staging system for hepatocellular carcinoma patients who have
undergone hepatectomy. J Gastroenterol. 41:250–256. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Omagari K, Honda S, Kadokawa Y, et al:
Preliminary analysis of a newly proposed prognostic scoring system
(SLiDe score) for hepatocellular carcinoma. J Gastroenterol
Hepatol. 19:805–811. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
OuYang PY, Su Z, Ma XH, Mao YP, Liu MZ and
Xie FY: Comparison of TNM staging systems for nasopharyngeal
carcinoma, and proposal of a new staging system. Br J Cancer.
109:2987–2997. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim BK, Han KH, Park YN, et al: Prediction
of microvascular invasion before curative resection of
hepatocellular carcinoma. J Surg Oncol. 97:246–252. 2008.
View Article : Google Scholar
|
|
20
|
Han KH, Kudo M, Ye SL, et al: Asian
consensus workshop report: expert consensus guideline for the
management of intermediate and advanced hepatocellular carcinoma in
Asia. Oncology. 81(Suppl 1): 158–164. 2011. View Article : Google Scholar
|
|
21
|
Pons F, Varela M and Llovet JM: Staging
systems in hepatocellular carcinoma. HPB (Oxford). 7:35–41. 2005.
View Article : Google Scholar
|
|
22
|
Chung H, Kudo M, Takahashi S, et al:
Review of current staging systems for hepatocellular carcinoma.
Hepatol Res. 37(Suppl 2): S210–S215. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Toyoda H, Kumada T, Kiriyama S, et al:
Comparison of the usefulness of three staging systems for
hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J
Gastroenterol. 100:1764–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Toyama T, Hiramatsu N, Yakushijin T, et
al: A new prognostic system for hepatocellular carcinoma including
recurrent cases: a study of 861 patients in a single institution. J
Clin Gastroenterol. 42:317–322. 2008.PubMed/NCBI
|
|
25
|
Prospective validation of the CLIP score:
a new prognostic system for patients with cirrhosis and
hepatocellular carcinoma. The Cancer of the Liver Italian Program
(CLIP) Investigators. Hepatology. 31:840–845. 2000. View Article : Google Scholar
|
|
26
|
Hsu CY, Hsia CY, Huang YH, et al:
Selecting an optimal staging system for hepatocellular carcinoma:
comparison of 5 currently used prognostic models. Cancer.
116:3006–3014. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shao YY, Lu LC, Lin ZZ, et al: Prognosis
of advanced hepatocellular carcinoma patients enrolled in clinical
trials can be classified by current staging systems. Br J Cancer.
107:1672–1677. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
op den Winkel M, Nagel D, Sappl J, et al:
Prognosis of patients with hepatocellular carcinoma. Validation and
ranking of established staging-systems in a large western
HCC-cohort. PLoS One. 7:e450662012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kudo M, Chung H and Osaki Y: Prognostic
staging system for hepatocellular carcinoma (CLIP score): its value
and limitations, and a proposal for a new staging system, the Japan
Integrated Staging Score (JIS score). J Gastroenterol. 38:207–215.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luo KZ, Itamoto T, Amano H, et al:
Comparative study of the Japan Integrated Stage (JIS) and modified
JIS score as a predictor of survival after hepatectomy for
hepatocellular carcinoma. J Gastroenterol. 43:369–377. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ikai I, Takayasu K, Omata M, et al: A
modified Japan Integrated Stage score for prognostic assessment in
patients with hepatocellular carcinoma. J Gastroenterol.
41:884–892. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wakabayashi H, Ishimura K, Izuishi K,
Karasawa Y and Maeta H: Evaluation of liver function for hepatic
resection for hepatocellular carcinoma in the liver with damaged
parenchyma. J Surg Res. 116:248–252. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lau H, Man K, Fan ST, Yu WC, Lo CM and
Wong J: Evaluation of preoperative hepatic function in patients
with hepatocellular carcinoma undergoing hepatectomy. Br J Surg.
84:1255–1259. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fukuda S, Itamoto T, Amano H, et al:
Clinicopathologic features of hepatocellular carcinoma patients
with compensated cirrhosis surviving more than 10 years after
curative hepatectomy. World J Surg. 31:345–352. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim SH, Choi SB, Lee JG, et al: Prognostic
factors and 10-year survival in patients with hepatocellular
carcinoma after curative hepatectomy. J Gastrointest Surg.
15:598–607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Matsuda M, Omata F, Fuwa S, et al:
Prognosis of patients with hepatocellular carcinoma treated solely
with transcatheter arterial chemoembolization: risk factors for
one-year recurrence and two-year mortality (preliminary data).
Intern Med. 52:847–853. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Llovet JM, Fuster J and Bruix J: The
Barcelona approach: diagnosis, staging, and treatment of
hepatocellular carcinoma. Liver Transpl. 10:S115–S120. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Leung TW, Tang AM, Zee B, et al:
Construction of the Chinese University Prognostic Index for
hepatocellular carcinoma and comparison with the TNM staging
system, the Okuda staging system, and the Cancer of the Liver
Italian Program staging system: a study based on 926 patients.
Cancer. 94:1760–1769. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kinoshita A, Onoda H, Imai N, et al: The
Glasgow Prognostic Score, an inflammation based prognostic score,
predicts survival in patients with hepatocellular carcinoma. BMC
Cancer. 13:522013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Boleslawski E, Petrovai G, Truant S, et
al: Hepatic venous pressure gradient in the assessment of portal
hypertension before liver resection in patients with cirrhosis. Br
J Surg. 99:855–863. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hidaka M, Takatsuki M, Soyama A, et al:
Intraoperative portal venous pressure and long-term outcome after
curative resection for hepatocellular carcinoma. Br J Surg.
99:1284–1289. 2012. View Article : Google Scholar : PubMed/NCBI
|
